TY  - GEN
AU  - Chevallier,P
AU  - Labopin,M
AU  - Milpied,N
AU  - Bilger,K
AU  - Socié,G
AU  - Yakoub-Agha,I
AU  - Michallet,M
AU  - Bulabois,C-E
AU  - Maury,S
AU  - Beguin,Y
AU  - Bay,J-O
AU  - Blaise,D
AU  - Maillard,N
AU  - Guillerm,G
AU  - Daguindeau,E
AU  - Raus,N
AU  - Mohty,M
TI  - Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
SN  - 1476-5365
PY  - 2015///0702
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - France
KW  - HLA Antigens
KW  - chemistry
KW  - Hematologic Neoplasms
KW  - mortality
KW  - Hodgkin Disease
KW  - Humans
KW  - Lymphoma, Non-Hodgkin
KW  - Male
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Myeloproliferative Disorders
KW  - Proportional Hazards Models
KW  - Recurrence
KW  - Retrospective Studies
KW  - Societies, Medical
KW  - Stem Cell Transplantation
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1038/bmt.2013.186
ER  -